Cargando…
Monoamine Levels and Parkinson’s Disease Progression: Evidence From a High-Performance Liquid Chromatography Study
Parkinson’s disease (PD) is associated with dysfunction of monoamine neurotransmitter systems. We investigated changes in the levels of monoamine and their metabolites in PD patients, together with their association to clinical profiles. PD patients and age-matched control subjects (n = 40 per group...
Autores principales: | Wichit, Patsorn, Thanprasertsuk, Sekh, Phokaewvarangkul, Onanong, Bhidayasiri, Roongroj, Bongsebandhu-phubhakdi, Saknan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358115/ https://www.ncbi.nlm.nih.gov/pubmed/34393700 http://dx.doi.org/10.3389/fnins.2021.605887 |
Ejemplares similares
-
Levodopa-induced dyskinesia in early-onset Parkinson’s disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand
por: Thanprasertsuk, Sekh, et al.
Publicado: (2023) -
How to spot ocular abnormalities in progressive supranuclear palsy? A practical review
por: Phokaewvarangkul, Onanong, et al.
Publicado: (2019) -
Parkinsonism hyperpyraexia syndrome in Parkinson's disease patients undergoing deep brain stimulation: An indirect consequence of COVID-19 lockdowns
por: Phokaewvarangkul, Onanong, et al.
Publicado: (2021) -
Using Machine Learning for Predicting the Best Outcomes With Electrical Muscle Stimulation for Tremors in Parkinson’s Disease
por: Phokaewvarangkul, Onanong, et al.
Publicado: (2021) -
Profiling the most elderly parkinson’s disease patients: Does age or disease duration matter?
por: Virameteekul, Sasivimol, et al.
Publicado: (2021)